RaySearch Laboratories ABRSLBF +0.81%92 Pretax Margin % is 23.42% as of Mar. 2026, which is 86% above its 10-year median of 12.62. GuruFocus rates RSLBF with a GF Score™ of 92/100 and a GF Value™ of $20.80 (Fairly Valued). The stock has 2 warning signs investors should review. Among 666 Healthcare Providers & Services companies, RaySearch Laboratories AB ranks better than 91.89% on this metric.
The historical rank and industry rank for RaySearch Laboratories AB's Pretax Margin % or its related term are showing as below:
RSLBF'
s Pretax Margin % Range Over the Past 10 Years
Min: -9.14 Med: 12.62 Max: 37.27
Current: 21.82
RSLBF's Pretax Margin % is ranked better than 91.89% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 4.01
vs RSLBF: 21.82
RaySearch Laboratories AB (OTCPK:RSLBF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
RaySearch Laboratories AB Pretax Margin % Related Terms
RaySearch Laboratories AB Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RSLBF vs VEEV, BTSG, TEM: Pretax Margin % Comparison
For the Health Information Services subindustry, RaySearch Laboratories AB's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RaySearch Laboratories AB Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where RaySearch Laboratories AB's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RaySearch Laboratories AB (RSLBF) has a Pretax Margin % of 23.42% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on RaySearch Laboratories AB and its competitors. This is 86% above median its historical median of 12.62. According to the industry distribution chart, RaySearch Laboratories AB ranks #54 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 8.1%.
Is RaySearch Laboratories AB's Pretax Margin % too high?
RaySearch Laboratories AB's current Pretax Margin % of 23.42% is 86% above median its 10-year median of 12.62. The Healthcare Providers & Services industry median Pretax Margin % is 4.01. RaySearch Laboratories AB's value of 23.42% is 484% above this industry median. Based on the distribution chart, RaySearch Laboratories AB ranks #54 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, RaySearch Laboratories AB has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Pretax Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, RaySearch Laboratories AB ranks #54 out of 666 companies for Pretax Margin %. This places RaySearch Laboratories AB in the top 8% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 4.01. RaySearch Laboratories AB's value of 23.42% is 484% above this benchmark. While the company's 10-year median is 12.62 vs. the industry median of 4.01, RaySearch Laboratories AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.01, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RaySearch Laboratories AB's current Pretax Margin % of 23.42% is 484% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on RaySearch Laboratories AB and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RaySearch Laboratories AB's current Pretax Margin % is 23.42%, which is 86% above median its own 10-year median of 12.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (RSLBF) is currently considered Fairly Valued. The stock's GF Value™ is $20.80, compared to a current price of $21.17 — trading 1.8% above its estimated fair value. The current Pretax Margin % is 23.42%, which is 86% above median its 10-year median of 12.62 and 484% above the Healthcare Providers & Services industry median of 4.01. RaySearch Laboratories AB's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For RaySearch Laboratories AB (RSLBF), the current Pretax Margin % is 23.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RaySearch Laboratories AB (RSLBF) Overvalued in 2026?
Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued.
The current stock price of $21.17 is trading 1.8% above its estimated GF Value™ of $20.80.
GuruFocus considers RaySearch Laboratories AB to be Fairly Valued.
Key valuation signals for RSLBF:
Pretax Margin %: 23.42% (86% above median its 10-year median of 12.62)
GF Value™: $20.80 vs. price of $21.17 (1.8% above fair value)
Industry Position: 484% above the Healthcare Providers & Services median (#54 of 666)
No single metric tells the full story. See the RSLBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
92GF Score
Get the complete analysis for RSLBF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSLBF has been successfully added to your 
